Optimized tacrolimus dosing strategy in kidney transplant recipients receiving nirmatrelvir-ritonavir for COVID-19
View ORCID ProfileHan Yan, Shanbiao Hu, Hedong Zhang, Yangang Zhou, Rao Fu, Ping Xu, Hualin Cai, View ORCID ProfileXi Li, View ORCID ProfileGongbin Lan
doi: https://doi.org/10.1101/2024.08.22.24312416
Han Yan
1Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha Hunan, P.R. China 410011
2Institute of Clinical Pharmacy, Central South University, Changsha, China
Shanbiao Hu
3Department of Kidney Transplantation, The Second Xiangya Hospital, Central South University, Changsha Hunan, P.R. China 410011
Hedong Zhang
3Department of Kidney Transplantation, The Second Xiangya Hospital, Central South University, Changsha Hunan, P.R. China 410011
Yangang Zhou
1Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha Hunan, P.R. China 410011
2Institute of Clinical Pharmacy, Central South University, Changsha, China
Rao Fu
1Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha Hunan, P.R. China 410011
2Institute of Clinical Pharmacy, Central South University, Changsha, China
Ping Xu
1Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha Hunan, P.R. China 410011
2Institute of Clinical Pharmacy, Central South University, Changsha, China
Hualin Cai
1Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha Hunan, P.R. China 410011
2Institute of Clinical Pharmacy, Central South University, Changsha, China
Xi Li
4Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan, P.R. China 410008; Institute of Clinical Pharmacology, Central South University; Hunan Key Laboratory of Pharmacogenetics, Changsha Hunan, P.R. China 410008
Gongbin Lan
3Department of Kidney Transplantation, The Second Xiangya Hospital, Central South University, Changsha Hunan, P.R. China 410011
Data availability statement
The data that support the findings of this study is available from the corresponding author upon a reasonable request.
Posted August 22, 2024.
Optimized tacrolimus dosing strategy in kidney transplant recipients receiving nirmatrelvir-ritonavir for COVID-19
Han Yan, Shanbiao Hu, Hedong Zhang, Yangang Zhou, Rao Fu, Ping Xu, Hualin Cai, Xi Li, Gongbin Lan
medRxiv 2024.08.22.24312416; doi: https://doi.org/10.1101/2024.08.22.24312416
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2821)
- Dermatology (242)
- Emergency Medicine (425)
- Epidemiology (12513)
- Forensic Medicine (10)
- Gastroenterology (798)
- Genetic and Genomic Medicine (4387)
- Geriatric Medicine (399)
- Health Economics (711)
- Health Informatics (2829)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4149)
- Nursing (220)
- Nutrition (614)
- Oncology (2186)
- Ophthalmology (622)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (263)
- Palliative Medicine (81)
- Pathology (483)
- Pediatrics (1166)
- Primary Care Research (481)
- Public and Global Health (6732)
- Radiology and Imaging (1480)
- Respiratory Medicine (895)
- Rheumatology (429)
- Sports Medicine (361)
- Surgery (469)
- Toxicology (57)
- Transplantation (198)
- Urology (173)